Aller au contenu
BIBLIOTHÈQUE DE RECHERCHE

Santé cardiovasculaire

Tension, forme, lipides et rythme.

143articles

10années de publication

Sources vérifiées · Méthode de sélection

Publication years in this collection
Counts and coverage
  • 2017 · 12
  • 2018 · 10
  • 2019 · 12
  • 2020 · 16
  • 2021 · 16
  • 2022 · 16
  • 2023 · 13
  • 2024 · 13
  • 2025 · 8
  • 2026 · 27

Counts describe this library, not the strength of evidence.

Comprendre ce type de preuve

Separate prevention outcomes, risk-factor changes and screening performance. A drug trial in established disease, an exercise blood-pressure analysis and a smartwatch alert study cannot be treated as equivalent evidence for a healthy individual.

Parcourir les articles

143 articles

Réinitialiser
·Étude de cohorte

Systolic blood pressure of 130 mmHg or more at age 50 linked to higher dementia risk

In 8639 people from the Whitehall II cohort, systolic blood pressure of 130 mmHg or higher at age 50 was linked to a higher dementia risk (HR 1.38; 95% CI 1.11, 1.70), but no link was seen at age 60 or 70. This is an observational association with dementia recorded from health records, so it does not show that lowering blood pressure at 50 prevents dementia.

European heart journal

Lecture structuréeLire l’étude →
·Méta-analyse observationnelle

Any alcohol linked to higher hypertension risk in men; in women, only above 2 drinks a day

Across 20 cohort articles (361 254 people, 90 160 new hypertension cases), men drinking 1 to 2 drinks a day had higher hypertension risk than abstainers (RR 1.19, 95% CI 1.07-1.31), while women at that level did not (RR 0.94, 0.88-1.01). These are observational cohort data, so they show association and cannot prove the sex difference is biological.

Journal of the American Heart Association

Lecture structuréeLire l’étude →
·Étude de cohorte

After gestational diabetes: far more type 2 diabetes, more hypertension and heart disease

In a UK primary care database, 9,118 women with gestational diabetes had far higher rates of later type 2 diabetes (IRR 21.96) and hypertension (IRR 1.85) than 37,281 matched women, and a higher rate of ischemic heart disease (IRR 2.78, 95% CI 1.37-5.66). The heart disease finding rests on few events over short follow-up, so its size is uncertain.

PLoS medicine

Lecture structuréeLire l’étude →
·Essai randomisé

Gastric bypass cut blood pressure drug needs in obese patients with hypertension in a 1-year trial

In 100 patients with obesity and hypertension, 83.7% (41 of 49) of those randomized to gastric bypass plus medication cut their antihypertensive drugs by at least 30% while keeping blood pressure controlled at 12 months, versus 12.8% (6 of 47) on medication alone (rate ratio 6.6, 95% CI 3.1-14.0). It was a single-center, unblinded trial with one year of follow-up, so long-term effects and safety are not shown here.

Circulation

Lecture structuréeLire l’étude →
·Étude transversale

Current smokers had lower measured blood pressure than nonsmokers in Chinese men

In a cross-sectional study of men in China, adjusted diastolic pressure and mean arterial pressure were lower in current smokers than nonsmokers (P < 0.05), while former smokers had higher odds of hypertension than never smokers (OR 1.48, 95% CI 1.01 to 2.18). A one-time snapshot cannot say whether smoking or quitting changed blood pressure.

BMC public health

Lecture structuréeLire l’étude →
·Étude de cohorte

Higher triglyceride-glucose index linked to more new hypertension over 9 years in China

Among 4686 people followed for 9 years, 2047 developed hypertension, and the 9-year incidence rose from 28.5% in the lowest quarter of the triglyceride-glucose (TyG) index to 59.8% in the highest (p for trend < 0.001). This is an association in one Chinese cohort, and the abstract gives no adjusted risk estimates or the factors that were adjusted for.

Lipids in health and disease

Lecture structuréeLire l’étude →
·Méta-analyse observationnelle

Higher dietary magnesium linked to slightly lower hypertension risk in cohort studies

Pooling 9 articles covering 10 cohort studies (180,566 participants, 20,119 hypertension cases), the highest dietary magnesium intake was linked to 8% lower hypertension risk than the lowest (RR 0.92, 95% CI 0.86-0.98). Blood magnesium showed only a marginal link (RR 0.91, 0.80-1.02), and observational cohorts cannot prove magnesium itself lowers blood pressure.

Nutrition journal

Lecture structuréeLire l’étude →
·Essai randomisé

Evolocumab added to statins lowered LDL by 59% and reduced cardiovascular events

In 27,564 people with atherosclerotic cardiovascular disease already on a statin, adding evolocumab lowered LDL cholesterol by 59% versus placebo at 48 weeks and reduced the primary composite of cardiovascular events to 9.8% from 11.3% over a median 2.2 years (HR 0.85, 95% CI 0.79 to 0.92). Amgen funded the trial, follow-up was short, and only people with established disease took part, so the result does not speak to healthy people or to long-term safety.

The New England Journal of Medicine

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Potassium supplements lowered blood pressure by a few mm Hg in 23 hypertension trials

Across 23 placebo-controlled trials with 1213 participants, oral potassium lowered systolic blood pressure by 4.25 mm Hg (95% CI -5.96 to -2.53) and diastolic by 2.53 mm Hg versus placebo in primary hypertension. The trials differed noticeably on the diastolic result (I2 = 65%), and the abstract's safety claim comes with no adverse-event numbers.

PloS one

Lecture structuréeLire l’étude →